Evidence map›Paper›PMID 25572524›Full record

ArticleFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association2015

Licochalcone-A induces intrinsic and extrinsic apoptosis via ERK1/2 and p38 phosphorylation-mediated TRAIL expression in head and neck squamous carcinoma FaDu cells.

Mi-Ra Park, Su-Gwan Kim, In-A Cho, Dahye Oh, Kyeong-Rok Kang, Sook-Young Lee, Sung-Min Moon, Seung Sik Cho, Goo Yoon, Chun Sung Kim and 6 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03292822 (Apoptotic and Anti-Proliferative Effects of Licorice Extract), which is not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03292822 phase1completednot on this mapstarted 2021, after this paper: background citation

Apoptotic and Anti-Proliferative Effects of Licorice Extract (Licochalcone A) and Paclitaxel Chemotherapy on Human Oral Squamous Cell Carcinoma Cell Line

TypeinterventionalSponsorCairo UniversityRan2021 to 2023Enrolled18ConditionsSquamous Cell CarcinomaArmsLicochalcone A, Paclitaxel
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Mi-Ra ParkOral Biology Research Institute, Chosun University, Gwangju 501-759, Republic of Korea; Department of Biomedical Science, CHA University, Seongnam, Gyeongghi-do 487-101, Republic of Korea.
Su-Gwan KimOral Biology Research Institute, Chosun University, Gwangju 501-759, Republic of Korea; Regional Innovation Center for Dental Science and Engineering, Chosun University, Gwangju 501-759, Republic of Korea.
In-A ChoOral Biology Research Institute, Chosun University, Gwangju 501-759, Republic of Korea; Regional Innovation Center for Dental Science and Engineering, Chosun University, Gwangju 501-759, Republic of Korea.
Dahye OhOral Biology Research Institute, Chosun University, Gwangju 501-759, Republic of Korea; Regional Innovation Center for Dental Science and Engineering, Chosun University, Gwangju 501-759, Republic of Korea.
Kyeong-Rok KangOral Biology Research Institute, Chosun University, Gwangju 501-759, Republic of Korea; Regional Innovation Center for Dental Science and Engineering, Chosun University, Gwangju 501-759, Republic of Korea.
Sook-Young LeeOral Biology Research Institute, Chosun University, Gwangju 501-759, Republic of Korea; Regional Innovation Center for Dental Science and Engineering, Chosun University, Gwangju 501-759, Republic of Korea.
Sung-Min MoonOral Biology Research Institute, Chosun University, Gwangju 501-759, Republic of Korea.
Seung Sik ChoDepartment of Pharmacy, College of Pharmacy, Mokpo National University, Muan, Jeonnam 353-729, Republic of Korea.
Goo YoonDepartment of Pharmacy, College of Pharmacy, Mokpo National University, Muan, Jeonnam 353-729, Republic of Korea.
Chun Sung KimOral Biology Research Institute, Chosun University, Gwangju 501-759, Republic of Korea.
Ji-Su OhOral Biology Research Institute, Chosun University, Gwangju 501-759, Republic of Korea; Regional Innovation Center for Dental Science and Engineering, Chosun University, Gwangju 501-759, Republic of Korea.
Jae-Seek YouOral Biology Research Institute, Chosun University, Gwangju 501-759, Republic of Korea.
Do Kyung KimOral Biology Research Institute, Chosun University, Gwangju 501-759, Republic of Korea; Regional Innovation Center for Dental Science and Engineering, Chosun University, Gwangju 501-759, Republic of Korea.
Yo-Seob SeoOral Biology Research Institute, Chosun University, Gwangju 501-759, Republic of Korea.
Hee-Jeong ImDepartment of Biochemistry, Rush University Medical Center, Chicago, IL 60612, USA.
Jae-Sung KimThe Division of Natural Medical Sciences, College of Health Science, Chosun University, Gwangju 501-759, Republic of Korea. Electronic address: js_kim@chosun.ac.kr.
Chosun University · KRMokpo National University · KRRush University Medical Center · US

Funding

Pain Mechanisms of Knee Joint OsteoarthritisR01AR062136 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI CHEN, DI · 2012 to 2016
$1.7M
Pathological Role of bFGF in Human Adult Articular CartilageR01AR053220 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI SAMPEN, HEE-JEONG IM · 2006 to 2010
$1.6M
OSTEOARTHRITIS AND KNEE JOINT PAINI01BX002647 · VA · JESSE BROWN VA MEDICAL CENTER · PI SAMPEN, HEE-JEONG IM · 2015 to 2023
–
BLRD VA I01 BX002647NIAMS NIH HHS R01 AR053220NIAMS NIH HHS R01 AR062136
6 · The paper itself

Abstract

We investigated Licochalcone-A (Lico-A)-induced apoptosis and the pathway underlying its activity in a pharyngeal squamous carcinoma FaDu cell line. Lico-A purified from root of Glycyrrhiza inflata had cytotoxic effects, significantly increasing cell death in FaDu cells. Using a cell viability assay, we determined that the IC50 value of Lico-A in FaDu cells was approximately 100 µM. Chromatin condensation was observed in FaDu cells treated with Lico-A for 24 h. Consistent with this finding, the number of apoptotic cells increased in a time-dependent manner when FaDu cells were treated with Lico-A. TRAIL was significantly up-regulated in Lico-A-treated FaDu cells in a dose-dependent manner. Apoptotic factors such as caspases and PARP were subsequently activated in a caspase-dependent manner. In addition, levels of pro-apoptotic factors increased significantly in response to Lico-A treatment, while levels of anti-apoptotic factors decreased. Lico-A-induced TRAIL expression was mediated in part by a MAPK signaling pathway involving ERK1/2 and p38. In xenograft mouse model, Lico-A treatment effectively suppressed the growth of FaDu cell xenografts by activating caspase-3, without affecting the body weight of mice. Taken together, these data suggest that Lico-A has potential chemopreventive effects and should therefore be developed as a chemotherapeutic agent for pharyngeal squamous carcinoma.

Indexed as

AnimalsAntineoplastic AgentsApoptosisCarcinoma, Squamous CellCaspase 3Caspase 7Cell Line, TumorCell SurvivalChalconesChemopreventionGlycyrrhizaHead and Neck NeoplasmsHumansInhibitory Concentration 50KeratinocytesMaleAntineoplastic AgentsCasp3 protein, mouseCasp7 protein, mouseCaspase 3Caspase 7Chalconeslicochalcone AMitogen-Activated Protein Kinase 3p38 Mitogen-Activated Protein KinasesPlant ExtractsTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, humanApoptosisChemopreventionFaDu cellsLicochalcone-APharyngeal squamous carcinoma

Identifiers

PMID25572524
PMCPMC4522946
OpenAlexW2073433258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.